While compounding is strictly limited to the preparation of medicines for individual patients based on a valid prescription, the facility was found to be manufacturing and marketing GIP/GLP-1-based products, including semaglutide, tirzepatide, and combination formulations, for broader commercial distribution, particularly for weight management purposes, SAHPRA said
Loss of transcriptional heterogeneity in aged human muscle stem cells
This may increase fat metabolism, leading to weight loss
injection volume: 3 L and the elution gradient is shown in Table 3
Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer
This finding indicate that current fasting guidelines may be insufficient for patients on GLP-1 RAs, thereby increasing their aspiration risk [19]